1
|
Magkoutas K, Arm P, Meboldt M, Schmid Daners M. Physiologic Data-Driven Iterative Learning Control for Left Ventricular Assist Devices. Front Cardiovasc Med 2022; 9:922387. [PMID: 35911509 PMCID: PMC9326058 DOI: 10.3389/fcvm.2022.922387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2022] [Accepted: 06/20/2022] [Indexed: 11/25/2022] Open
Abstract
Continuous flow ventricular assist devices (cfVADs) constitute a viable and increasingly used therapy for end-stage heart failure patients. However, they are still operating at a fixed-speed mode that precludes physiological cfVAD response and it is often related to adverse events of cfVAD therapy. To ameliorate this, various physiological controllers have been proposed, however, the majority of these controllers do not account for the lack of pulsatility in the cfVAD operation, which is supposed to be beneficial for the physiological function of the cardiovascular system. In this study, we present a physiological data-driven iterative learning controller (PDD-ILC) that accurately tracks predefined pump flow trajectories, aiming to achieve physiological, pulsatile, and treatment-driven response of cfVADs. The controller has been extensively tested in an in-silico environment under various physiological conditions, and compared with a physiologic pump flow proportional-integral-derivative controller (PF-PIDC) developed in this study as well as the constant speed (CS) control that is the current state of the art in clinical practice. Additionally, two treatment objectives were investigated to achieve pulsatility maximization and left ventricular stroke work (LVSW) minimization by implementing copulsation and counterpulsation pump modes, respectively. Under all experimental conditions, the PDD-ILC as well as the PF-PIDC demonstrated highly accurate tracking of the reference pump flow trajectories, outperforming existing model-based iterative learning control approaches. Additionally, the developed controllers achieved the predefined treatment objectives and resulted in improved hemodynamics and preload sensitivities compared to the CS support.
Collapse
Affiliation(s)
| | | | | | - Marianne Schmid Daners
- Product Development Group Zurich, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland
| |
Collapse
|
2
|
Jing T, Xin T, Wang F, Zhang Z, Zhou L. Control Strategy Design of a Microblood Pump Based on Heart-Rate Feedback. MICROMACHINES 2022; 13:mi13030358. [PMID: 35334650 PMCID: PMC8951086 DOI: 10.3390/mi13030358] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Revised: 02/19/2022] [Accepted: 02/21/2022] [Indexed: 11/16/2022]
Abstract
Based on the nonlinear relationship between heart rate and stroke volume, a flow model of left ventricular circulation was improved, and a variable-speed blood-pump control strategy based on heart-rate feedback was proposed. The control strategy was implemented on a system combining the rotary blood pump and blood circulation models of heart failure. The aortic flow of a healthy heart at different heart rates was the desired control goal. Changes in heart rate were monitored and pump speed was adjusted so that the output flow and aortic pressure of the system would match a normal heart in real time to achieve the best auxiliary state. After simulation with MATLAB, the cardiac output satisfied the ideal perfusion requirements at different heart rates, and aortic pressure demonstrated lifting and had good pulsatile performance when a variable-speed blood pump was used. The coupled model reflected the relationship between hemodynamic parameters at different heart rates with the use of the variable-speed blood pump, providing a theoretical basis for the blood-pump-assisted treatment of heart failure and the design of physiological control strategies.
Collapse
Affiliation(s)
| | | | | | | | - Ling Zhou
- Correspondence: ; Tel.: +86-138-1547-7737
| |
Collapse
|
3
|
Petersdorff-Campen KV, Dupuch MA, Magkoutas K, Meboldt M, Hierold C, Schmid Daners M. Pressure and Bernoulli-based Flow Measurement via a Tapered Inflow VAD Cannula. IEEE Trans Biomed Eng 2021; 69:1620-1629. [PMID: 34727020 DOI: 10.1109/tbme.2021.3123983] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVE Currently available ventricular assist devices provide continuous flow and do not adapt to the changing needs of patients. Physiological control algorithms have been proposed that adapt the pump speed based on the left ventricular pressure. However, so far, no clinically used pump can acquire this pressure. Therefore, for the validation of physiological control concepts in vivo, a system that can continuously and accurately provide the left ventricular pressure signal is needed. METHODS We demonstrate the integration of two pressure sensors into a tapered inflow cannula compatible with the HeartMate 3 (HM3) ventricular assist device. Selective laser melting was used to incorporate functional elements with a small footprint and therefore retain the geometry, function and implantability of the original cannula. The system was tested on a hybrid mock circulation system. Static and simulated physiological flow and pressure profiles were used to evaluate the combined pressure and flow sensing capabilities of the modified cannula. CONCLUSION The cannula prototypes enabled continuous pressure measurements at two points of their inner wall in the range of 100 and 200 mmHg. The developed, Bernoulli-based, two sensor model improved the accuracy of the measured simulated left ventricular pressure by eliminating the influence of flow inside the cannula. This method reduced the flow induced pressure uncertainty from up to 7.6 mmHg in single sensor measurements to 0.3 mmHg. Additionally, the two-sensor system and model enable the measurement of the blood flow through the pump with an accuracy of 0.140.04 L/min, without dedicated flow sensors.
Collapse
|
4
|
Koh V, Pauls J, Wu E, Stevens M, Ho Y, Lovell N, Lim E. A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation. Biomed Signal Process Control 2020. [DOI: 10.1016/j.bspc.2020.101914] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Meki M, Wang Y, Sethu P, Ghazal M, El-Baz A, Giridharan G. A Sensorless Rotational Speed-Based Control System for Continuous Flow Left Ventricular Assist Devices. IEEE Trans Biomed Eng 2020; 67:1050-1060. [DOI: 10.1109/tbme.2019.2928826] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
6
|
A Novel Control Method for Rotary Blood Pumps as Left Ventricular Assist Device Utilizing Aortic Valve State Detection. BIOMED RESEARCH INTERNATIONAL 2019; 2019:1732160. [PMID: 31886175 PMCID: PMC6927030 DOI: 10.1155/2019/1732160] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Revised: 06/29/2019] [Accepted: 08/08/2019] [Indexed: 12/28/2022]
Abstract
A novel control method for rotary blood pumps is proposed relying on two different objectives: regulation of pump flow in accordance with desired value and the maintenance of partial support with an open aortic valve by the variation of pump speed. The estimation of pump flow and detection of aortic valve state was performed with mathematical models describing the first- and second generation of Sputnik rotary blood pumps. The control method was validated using a cardiovascular system model. The state of the aortic valve was detected with a mean accuracy of 91% for Sputnik 1 and 96.2% for Sputnik 2 when contractility, heart rate, and systemic vascular resistance was changed. In silico results for both pumps showed that the proposed control method can achieve the desired pump flow level and maintain the open state of the aortic valve by periodically switching between two objectives under contractility, heart rate, and systemic vascular resistance changes. The proposed method showed its potential for safe operation without adverse events and for the improvement of chances for myocardial recovery.
Collapse
|
7
|
Wu EL, Stevens MC, Nestler F, Pauls JP, Bradley AP, Tansley G, Fraser JF, Gregory SD. A Starling-like total work controller for rotary blood pumps: An in vitro evaluation. Artif Organs 2019; 44:E40-E53. [PMID: 31520408 DOI: 10.1111/aor.13570] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 08/24/2019] [Accepted: 09/03/2019] [Indexed: 11/26/2022]
Abstract
Due to improved durability and survival rates, rotary blood pumps (RBPs) are the preferred left ventricular assist device when compared to volume displacement pumps. However, when operated at constant speed, RBPs lack a volume balancing mechanism which may result in left ventricular suction and suboptimal ventricular unloading. Starling-like controllers have previously been developed to balance circulatory volumes; however, they do not consider ventricular workload as a feedback and may have limited sensitivity to adjust RBP workload when ventricular function deteriorates or improves. To address this, we aimed to develop a Starling-like total work controller (SL-TWC) that matched the energy output of a healthy heart by adjusting RBP hydraulic work based on measured left ventricular stroke work and ventricular preload. In a mock circulatory loop, the SL-TWC was evaluated using a HeartWare HVAD in a range of simulated patient conditions. These conditions included changes in systemic hypertension and hypotension, pulmonary hypertension, blood circulatory volume, exercise, and improvement and deterioration of ventricular function by increasing and decreasing ventricular contractility. The SL-TWC was compared to constant speed control where RBP speed was set to restore cardiac output to 5.0 L/min at rest. Left ventricular suction occurred with constant speed control during pulmonary hypertension but was prevented with the SL-TWC. During simulated exercise, the SL-TWC demonstrated reduced LVSW (0.51 J) and greater RBP flow (9.2 L/min) compared to constant speed control (LVSW: 0.74 J and RBP flow: 6.4 L/min). In instances of increased ventricular contractility, the SL-TWC reduced RBP hydraulic work while maintaining cardiac output similar to the rest condition. In comparison, constant speed overworked and increased cardiac output. The SL-TWC balanced circulatory volumes by mimicking the Starling mechanism, while also considering changes in ventricular workload. Compared to constant speed control, the SL-TWC may reduce complications associated with volume imbalances, adapt to changes in ventricular function and improve patient quality of life.
Collapse
Affiliation(s)
- Eric L Wu
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Medicine, The University of Queensland, Brisbane, Queensland, Australia
| | - Michael C Stevens
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, Australia.,Central Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia
| | - Frank Nestler
- School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Queensland, Australia.,BiVACOR Pty Ltd, Brisbane, Queensland, Australia
| | - Jo P Pauls
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Engineering and Built Environment, Griffith University, Gold Coast, Queensland, Australia
| | - Andrew P Bradley
- School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Queensland, Australia.,Science and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland, Australia
| | - Geoff Tansley
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Engineering and Built Environment, Griffith University, Gold Coast, Queensland, Australia
| | - John F Fraser
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Medicine, The University of Queensland, Brisbane, Queensland, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering Technology Laboratory (ICETLAB), Critical Care Research Group, The Prince Charles Hospital, Brisbane, Queensland, Australia.,School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.,School of Engineering and Built Environment, Griffith University, Gold Coast, Queensland, Australia.,Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, Victoria, Australia.,Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
| |
Collapse
|
8
|
Stephens A, Gregory S, Tansley G, Busch A, Salamonsen R. In vitro evaluation of an adaptive Starling-like controller for dual rotary ventricular assist devices. Artif Organs 2019; 43:E294-E307. [PMID: 31188476 DOI: 10.1111/aor.13510] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 05/19/2019] [Accepted: 05/31/2019] [Indexed: 01/02/2023]
Abstract
Rotary ventricular assist devices (VADs) operated clinically under constant speed control (CSC) cannot respond adequately to changes in patient cardiac demand, resulting in sub-optimal VAD flow regulation. Starling-like control (SLC) of VADs mimics the healthy ventricular flow regulation and automatically adjusts VAD speed to meet varying patient cardiac demand. The use of a fixed control line (CL - the relationship between ventricular preload and VAD flow) limits the flow regulating capability of the controller, especially in the case of exercise. Adaptive SLC (ASLC) overcomes this limitation by allowing the controller to adapt the CL to meet a diverse range of circulatory conditions. This study evaluated ASLC, SLC and CSC in a biventricular supported mock circulation loop under the simulated conditions of exercise, sleep, fluid loading and systemic hypertension. Each controller was evaluated on its ability to remain within predefined limits of VAD flow, preload, and afterload. The ASLC produced superior cardiac output (CO) during exercise (10.1 L/min) compared to SLC (7.3 L/min) and CSC (6.3 L/min). The ASLC produced favourable haemodynamics during sleep, fluid loading and systemic hypertension and could remain within a predefined haemodynamic range in three out of four simulations, suggesting improved haemodynamic performance over SLC and CSC.
Collapse
Affiliation(s)
- Andrew Stephens
- Department of Mechanical and Aerospace Engineering, Monash University, Victoria, Australia.,Cardiorespiratory Engineering and Technology Laboratory, Baker Heart and Diabetes Institute, Victoria, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Queensland, Australia.,School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Shaun Gregory
- Department of Mechanical and Aerospace Engineering, Monash University, Victoria, Australia.,Cardiorespiratory Engineering and Technology Laboratory, Baker Heart and Diabetes Institute, Victoria, Australia.,Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Queensland, Australia.,School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Geoff Tansley
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Queensland, Australia.,School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Andrew Busch
- School of Engineering and Built Environment, Griffith Sciences, Griffith University, Queensland, Australia
| | - Robert Salamonsen
- Department of Epidemiology and Preventive Medicine, Monash University, Victoria, Australia
| |
Collapse
|
9
|
Stephens AF, Gregory SD, Salamonsen RF. The Importance of Venous Return in Starling-Like Control of Rotary Ventricular Assist Devices. Artif Organs 2018; 43:E16-E27. [PMID: 30094842 DOI: 10.1111/aor.13342] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2018] [Revised: 07/05/2018] [Accepted: 08/01/2018] [Indexed: 12/20/2022]
Abstract
Rotary ventricular assist devices (VADs) are less sensitive to preload than the healthy heart, resulting in inadequate flow regulation in response to changes in patient cardiac demand. Starling-like physiological controllers (SLCs) have been developed to automatically regulate VAD flow based on ventricular preload. An SLC consists of a cardiac response curve (CRC) which imposes a nonlinear relationship between VAD flow and ventricular preload, and a venous return line (VRL) which determines the return path of the controller. This study investigates the importance of a physiological VRL in SLC of dual rotary blood pumps for biventricular support. Two experiments were conducted on a physical mock circulation loop (MCL); the first compared an SLC with an angled physiological VRL (SLC-P) against an SLC with a vertical VRL (SLC-V). The second experiment quantified the benefit of a dynamic VRL, represented by a series of specific VRLs, which could adapt to different circulatory states including changes in pulmonary (PVR) and systemic (SVR) vascular resistance versus a fixed physiological VRL which was calculated at rest. In both sets of experiments, the transient controller responses were evaluated through reductions in preload caused by the removal of fluid from the MCL. The SLC-P produced no overshoot or oscillations following step changes in preload, whereas SLC-V produced 0.4 L/min (12.5%) overshoot for both left and right VADs. Additionally, the SLC-V had increased settling time and reduced controller stability as evidenced by transient controller oscillations. The transient results comparing the specific and standard VRLs demonstrated that specific VRL rise times were improved by between 1.2 and 4.7 s ( x ¯ = 3.05 s), while specific VRL settling times were improved by between 2.8 and 16.1 seconds ( x ¯ = 8.38 s) over the standard VRL. This suggests only a minor improvement in controller response time from a dynamic VRL compared to the fixed VRL. These results indicate that the use of a fixed physiologically representative VRL is adequate over a wide variety of physiological conditions.
Collapse
Affiliation(s)
- Andrew F Stephens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering and Built Environment, Griffith University, QLD, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering and Built Environment, Griffith University, QLD, Australia.,School of Mechanical and Aerospace Engineering, Monash University, VIC, Australia
| | - Robert F Salamonsen
- Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia.,Intensive Care Unit, Alfred Hospital, Prahran, VIC, Australia
| |
Collapse
|
10
|
Application of multiobjective neural predictive control to biventricular assistance using dual rotary blood pumps. Biomed Signal Process Control 2018. [DOI: 10.1016/j.bspc.2017.07.028] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
11
|
Petrou A, Pergantis P, Ochsner G, Amacher R, Krabatsch T, Falk V, Meboldt M, Daners MS. Response of a physiological controller for ventricular assist devices during acute patho-physiological events: an in vitro study. BIOMED ENG-BIOMED TE 2017; 62:623-633. [PMID: 28182575 DOI: 10.1515/bmt-2016-0155] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2016] [Accepted: 01/05/2017] [Indexed: 11/15/2022]
Abstract
The current paper analyzes the performance of a physiological controller for turbodynamic ventricular assist devices (tVADs) during acute patho-physiological events. The numerical model of the human blood circulation implemented on our hybrid mock circulation was extended in order to simulate the Valsalva maneuver (VM) and premature ventricular contractions (PVCs). The performance of an end-diastolic volume (EDV)-based physiological controller for VADs, named preload responsive speed (PRS) controller was evaluated under VM and PVCs. A slow and a fast response of the PRS controller were implemented by using a 3 s moving window, and a beat-to-beat method, respectively, to extract the EDV index. The hemodynamics of a pathological circulation, assisted by a tVAD controlled by the PRS controller were analyzed and compared with a constant speed support case. The results show that the PRS controller prevented suction during the VM with both methods, while with constant speed, this was not the case. On the other hand, the pump flow reduction with the PRS controller led to low aortic pressure, while it remained physiological with the constant speed control. Pump backflow was increased when the moving window was used but it avoided sudden undesirable speed changes, which occurred during PVCs with the beat-to-beat method. In a possible clinical implementation of any physiological controller, the desired performance during frequent clinical acute scenarios should be considered.
Collapse
|
12
|
Petrou A, Lee J, Dual S, Ochsner G, Meboldt M, Schmid Daners M. Standardized Comparison of Selected Physiological Controllers for Rotary Blood Pumps: In Vitro Study. Artif Organs 2017; 42:E29-E42. [DOI: 10.1111/aor.12999] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2017] [Revised: 05/19/2017] [Accepted: 06/29/2017] [Indexed: 11/30/2022]
Affiliation(s)
- Anastasios Petrou
- Department of Mechanical and Process Engineering, Product Development Group Zurich; ETH Zurich; Zurich, Switzerland
| | - Jongseok Lee
- Department of Mechanical and Process Engineering, Product Development Group Zurich; ETH Zurich; Zurich, Switzerland
| | - Seraina Dual
- Department of Mechanical and Process Engineering, Product Development Group Zurich; ETH Zurich; Zurich, Switzerland
| | - Gregor Ochsner
- Department of Mechanical and Process Engineering, Product Development Group Zurich; ETH Zurich; Zurich, Switzerland
| | - Mirko Meboldt
- Department of Mechanical and Process Engineering, Product Development Group Zurich; ETH Zurich; Zurich, Switzerland
| | - Marianne Schmid Daners
- Department of Mechanical and Process Engineering, Product Development Group Zurich; ETH Zurich; Zurich, Switzerland
| |
Collapse
|
13
|
Petrou A, Monn M, Meboldt M, Schmid Daners M. A Novel Multi-objective Physiological Control System for Rotary Left Ventricular Assist Devices. Ann Biomed Eng 2017; 45:2899-2910. [PMID: 28900761 DOI: 10.1007/s10439-017-1919-0] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2017] [Accepted: 09/06/2017] [Indexed: 01/08/2023]
Abstract
Various control and monitoring algorithms have been proposed to improve the left-ventricular assist device (LVAD) therapy by reducing the still-occurring adverse events. We developed a novel multi-objective physiological control system that relies on the pump inlet pressure (PIP). Signal-processing algorithms have been implemented to extract the required features from the PIP. These features then serve for meeting various objectives: pump flow adaptation to the perfusion requirements, aortic valve opening for a predefined time, augmentation of the aortic pulse pressure, and monitoring of the LV pre- and afterload conditions as well as the cardiac rhythm. Controllers were also implemented to ensure a safe operation and prevent LV suction, overload, and pump backflow. The performance of the control system was evaluated in vitro, under preload, afterload and contractility variations. The pump flow adapted in a physiological manner, following the preload changes, while the aortic pulse pressure yielded a threefold increase compared to a constant-speed operation. The status of the aortic valve was detected with an overall accuracy of 86% and was controlled as desired. The proposed system showed its potential for a safe physiological response to varying perfusion requirements that reduces the risk of myocardial atrophy and offers important hemodynamic indices for patient monitoring during LVAD therapy.
Collapse
Affiliation(s)
- Anastasios Petrou
- Department of Mechanical and Process Engineering, Product Development Group Zurich, ETH Zurich, CLA G 21.1, Tannenstrasse 3, 8092, Zurich, Switzerland
| | - Marcial Monn
- Department of Mechanical and Process Engineering, Product Development Group Zurich, ETH Zurich, CLA G 21.1, Tannenstrasse 3, 8092, Zurich, Switzerland
| | - Mirko Meboldt
- Department of Mechanical and Process Engineering, Product Development Group Zurich, ETH Zurich, CLA G 21.1, Tannenstrasse 3, 8092, Zurich, Switzerland
| | - Marianne Schmid Daners
- Department of Mechanical and Process Engineering, Product Development Group Zurich, ETH Zurich, CLA G 21.1, Tannenstrasse 3, 8092, Zurich, Switzerland.
| |
Collapse
|
14
|
Stephens AF, Stevens MC, Gregory SD, Kleinheyer M, Salamonsen RF. In Vitro Evaluation of an Immediate Response Starling-Like Controller for Dual Rotary Blood Pumps. Artif Organs 2017; 41:911-922. [PMID: 28741664 DOI: 10.1111/aor.12962] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2016] [Revised: 03/26/2017] [Accepted: 04/12/2017] [Indexed: 11/30/2022]
Abstract
Rotary ventricular assist devices (VADs) are used to provide mechanical circulatory support. However, their lack of preload sensitivity in constant speed control mode (CSC) may result in ventricular suction or venous congestion. This is particularly true of biventricular support, where the native flow-balancing Starling response of both ventricles is diminished. It is possible to model the Starling response of the ventricles using cardiac output and venous return curves. With this model, we can create a Starling-like physiological controller (SLC) for VADs which can automatically balance cardiac output in the presence of perturbations to the circulation. The comparison between CSC and SLC of dual HeartWare HVADs using a mock circulation loop to simulate biventricular heart failure has been reported. Four changes in cardiovascular state were simulated to test the controller, including a 700 mL reduction in circulating fluid volume, a total loss of left and right ventricular contractility, reduction in systemic vascular resistance ( SVR) from 1300 to 600 dyne s/cm5, and an elevation in pulmonary vascular resistance ( PVR) from 100 to 300 dyne s/cm5. SLC maintained the left and right ventricular volumes between 69-214 mL and 29-182 mL, respectively, for all tests, preventing ventricular suction (ventricular volume = 0 mL) and venous congestion (atrial pressures > 20 mm Hg). Cardiac output was maintained at sufficient levels by the SLC, with systemic and pulmonary flow rates maintained above 3.14 L/min for all tests. With the CSC, left ventricular suction occurred during reductions in SVR, elevations in PVR, and reduction in circulating fluid simulations. These results demonstrate a need for a physiological control system and provide adequate in vitro validation of the immediate response of a SLC for biventricular support.
Collapse
Affiliation(s)
- Andrew F Stephens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering, Griffith University, QLD, Australia
| | - Michael C Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,Graduate School of Biomedical Engineering, University of New South Wales, NSW, Australia.,Sydney Medical School, University of Sydney, NSW, Australia
| | - Shaun D Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering, Griffith University, QLD, Australia.,School of Medicine, University of Queensland, QLD, Australia
| | - Matthias Kleinheyer
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.,School of Engineering, Griffith University, QLD, Australia
| | - Robert F Salamonsen
- Department of Epidemiology and Preventive Medicine, Monash University, VIC, Australia.,Intensive Care Unit, Alfred Hospital, Prahran, VIC, Australia
| |
Collapse
|
15
|
A Novel Mean-Value Model of the Cardiovascular System Including a Left Ventricular Assist Device. Cardiovasc Eng Technol 2017; 8:120-130. [PMID: 28466281 DOI: 10.1007/s13239-017-0303-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2016] [Accepted: 04/22/2017] [Indexed: 10/19/2022]
Abstract
Time-varying elastance models (TVEMs) are often used for simulation studies of the cardiovascular system with a left ventricular assist device (LVAD). Because these models are computationally expensive, they cannot be used for long-term simulation studies. In addition, their equilibria are periodic solutions, which prevent the extraction of a linear time-invariant model that could be used e.g. for the design of a physiological controller. In the current paper, we present a new type of model to overcome these problems: the mean-value model (MVM). The MVM captures the behavior of the cardiovascular system by representative mean values that do not change within the cardiac cycle. For this purpose, each time-varying element is manually converted to its mean-value counterpart. We compare the derived MVM to a similar TVEM in two simulation experiments. In both cases, the MVM is able to fully capture the inter-cycle dynamics of the TVEM. We hope that the new MVM will become a useful tool for researchers working on physiological control algorithms. This paper provides a plant model that enables for the first time the use of tools from classical control theory in the field of physiological LVAD control.
Collapse
|
16
|
Medvedev AL, Karimov JH, Kuban BD, Horvath DJ, Moazami N, Fukamachi K. Unlocking the box: basic requirements for an ideal ventricular assist device controller. Expert Rev Med Devices 2017; 14:393-400. [PMID: 28395539 DOI: 10.1080/17434440.2017.1318059] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
INTRODUCTION A modern ventricular assist device (VAD) system comprises an implantable rotary blood pump and external components located outside the patient's body: a wearable controller connected to the pump via a percutaneous cable, wearable rechargeable batteries, battery charger, alternating- and direct-current power supplies, and a hospital device to control and monitor the system. If the blood pump is the 'heart' of a VAD system, the controller is its 'brain.' The controller drives the pump's electrical motor; varies the pump speed or flow based on user commands or feedback signals; collects, processes, and stores data; performs self-diagnostics; transmits to and receives data from other system components, i.e., hospital monitor and batteries; and provides various types of user interface - audible, visual, and tactile. Areas covered: Here we describe the essential functions and basic design of the VAD external controller and give our views on the future of this technology. Expert commentary: Controllers for VAD systems are crucial to their successful operation. The current clinically available system comprises an external power supply and patient-friendly controller unit. Future controller solutions may enable remote hospital monitoring, more intuitive system interface, and the potential to use a single controller to automatically control a biventricular assist device configuration.
Collapse
Affiliation(s)
| | - Jamshid H Karimov
- b Department of Biomedical Engineering, Lerner Research Institute , Cleveland Clinic , Cleveland , OH , USA
| | - Barry D Kuban
- c Electronics Core, Medical Device Solutions, Lerner Research Institute , Cleveland Clinic , Cleveland , OH , USA
| | | | - Nader Moazami
- b Department of Biomedical Engineering, Lerner Research Institute , Cleveland Clinic , Cleveland , OH , USA.,e Department of Thoracic and Cardiovascular Surgery, Kaufman Center for Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support, Miller Family Heart and Vascular Institute , Cleveland Clinic , Cleveland , OH , USA
| | - Kiyotaka Fukamachi
- b Department of Biomedical Engineering, Lerner Research Institute , Cleveland Clinic , Cleveland , OH , USA
| |
Collapse
|
17
|
Mansouri M, Gregory SD, Salamonsen RF, Lovell NH, Stevens MC, Pauls JP, Akmeliawati R, Lim E. Preload-based Starling-like control of rotary blood pumps: An in-vitro evaluation. PLoS One 2017; 12:e0172393. [PMID: 28212401 PMCID: PMC5315328 DOI: 10.1371/journal.pone.0172393] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2016] [Accepted: 01/19/2017] [Indexed: 11/18/2022] Open
Abstract
Due to a shortage of donor hearts, rotary left ventricular assist devices (LVADs) are used to provide mechanical circulatory support. To address the preload insensitivity of the constant speed controller (CSC) used in conventional LVADs, we developed a preload-based Starling-like controller (SLC). The SLC emulates the Starling law of the heart to maintain mean pump flow ( QP¯) with respect to mean left ventricular end diastolic pressure (PLVEDm) as the feedback signal. The SLC and CSC were compared using a mock circulation loop to assess their capacity to increase cardiac output during mild exercise while avoiding ventricular suction (marked by a negative PLVEDm) and maintaining circulatory stability during blood loss and severe reductions in left ventricular contractility (LVC). The root mean squared hemodynamic deviation (RMSHD) metric was used to assess the clinical acceptability of each controller based on pre-defined hemodynamic limits. We also compared the in-silico results from our previously published paper with our in-vitro outcomes. In the exercise simulation, the SLC increased QP¯ by 37%, compared to only 17% with the CSC. During blood loss, the SLC maintained a better safety margin against left ventricular suction with PLVEDm of 2.7 mmHg compared to -0.1 mmHg for CSC. A transition to reduced LVC resulted in decreased mean arterial pressure (MAP) and QP¯ with CSC, whilst the SLC maintained MAP and QP¯. The results were associated with a much lower RMSHD value with SLC (70.3%) compared to CSC (225.5%), demonstrating improved capacity of the SLC to compensate for the varying cardiac demand during profound circulatory changes. In-vitro and in-silico results demonstrated similar trends to the simulated changes in patient state however the magnitude of hemodynamic changes were different, thus justifying the progression to in-vitro evaluation.
Collapse
Affiliation(s)
- Mahdi Mansouri
- Department of Biomedical Engineering, University of Malaya, Kuala Lumpur, Malaysia
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
| | - Shaun D. Gregory
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia
- School of Engineering, Griffith University, Brisbane, Queensland, Australia
| | - Robert F. Salamonsen
- Department of Intensive Care, Alfred Hospital, Prahran, Victoria, Australia
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Nigel H. Lovell
- Graduate School of Biomedical Engineering, UNSW, Sydney, New South Wales, Australia
| | - Michael C. Stevens
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
- Graduate School of Biomedical Engineering, UNSW, Sydney, New South Wales, Australia
- School of Medicine, University of Sydney, Camperdown, New South Wales, Australia
| | - Jo P. Pauls
- Innovative Cardiovascular Engineering and Technology Laboratory, Critical Care Research Group, the Prince Charles Hospital, Brisbane, Queensland, Australia
- School of Medicine, University of Queensland, Brisbane, Queensland, Australia
- School of Engineering, Griffith University, Brisbane, Queensland, Australia
| | - Rini Akmeliawati
- Department of Mechatronics Engineering, International Islamic University Malaysia, Kuala Lumpur
| | - Einly Lim
- Department of Biomedical Engineering, University of Malaya, Kuala Lumpur, Malaysia
- * E-mail:
| |
Collapse
|
18
|
Capoccia M. Mechanical Circulatory Support for Advanced Heart Failure: Are We about to Witness a New "Gold Standard"? J Cardiovasc Dev Dis 2016; 3:E35. [PMID: 29367578 PMCID: PMC5715724 DOI: 10.3390/jcdd3040035] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2016] [Revised: 12/03/2016] [Accepted: 12/06/2016] [Indexed: 01/08/2023] Open
Abstract
The impact of left ventricular assist devices (LVADs) for the treatment of advanced heart failure has played a significant role as a bridge to transplant and more recently as a long-term solution for non-eligible candidates. Continuous flow left ventricular assist devices (CF-LVADs), based on axial and centrifugal design, are currently the most popular devices in view of their smaller size, increased reliability and higher durability compared to pulsatile flow left ventricular assist devices (PF-LVADs). The trend towards their use is increasing. Therefore, it has become mandatory to understand the physics and the mathematics behind their mode of operation for appropriate device selection and simulation set up. For this purpose, this review covers some of these aspects. Although very successful and technologically advanced, they have been associated with complications such as pump thrombosis, haemolysis, aortic regurgitation, gastro-intestinal bleeding and arterio-venous malformations. There is perception that the reduced arterial pulsatility may be responsible for these complications. A flow modulation control approach is currently being investigated in order to generate pulsatility in rotary blood pumps. Thrombus formation remains the most feared complication that can affect clinical outcome. The development of a preoperative strategy aimed at the reduction of complications and patient-device suitability may be appropriate. Patient-specific modelling based on 3D reconstruction from CT-scan combined with computational fluid dynamic studies is an attractive solution in order to identify potential areas of stagnation or challenging anatomy that could be addressed to achieve the desired outcome. The HeartMate II (axial) and the HeartWare HVAD (centrifugal) rotary blood pumps have been now used worldwide with proven outcome. The HeartMate III (centrifugal) is now emerging as the new promising device with encouraging preliminary results. There are now enough pumps on the market: it is time to focus on the complications in order to achieve the full potential and selling-point of this type of technology for the treatment of the increasing heart failure patient population.
Collapse
Affiliation(s)
- Massimo Capoccia
- Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow G81 4DY, UK.
- Biomedical Engineering, University of Strathclyde, Glasgow G4 0NW, UK.
| |
Collapse
|
19
|
Control Algorithms for Rotary Blood Pumps Used in Assisted Circulation. BIOMEDICAL ENGINEERING-MEDITSINSKAYA TEKNIKA 2016. [DOI: 10.1007/s10527-016-9609-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
20
|
Petrou A, Ochsner G, Amacher R, Pergantis P, Rebholz M, Meboldt M, Schmid Daners M. A Physiological Controller for Turbodynamic Ventricular Assist Devices Based on Left Ventricular Systolic Pressure. Artif Organs 2016; 40:842-55. [DOI: 10.1111/aor.12820] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2016] [Revised: 06/10/2016] [Accepted: 07/06/2016] [Indexed: 11/29/2022]
Affiliation(s)
| | - Gregor Ochsner
- Product Development Group Zurich; Zurich Switzerland
- Institute for Dynamic Systems and Control, Department of Mechanical and Process Engineering, ETH Zurich; Zurich Switzerland
| | - Raffael Amacher
- Wyss Translation Center Zurich, ETH Zurich; Zurich Switzerland
| | - Panagiotis Pergantis
- Department of Cardiothoracic and Vascular Surgery; German Heart Institute Berlin; Berlin Germany
| | | | - Mirko Meboldt
- Product Development Group Zurich; Zurich Switzerland
| | | |
Collapse
|